Prosecution Insights
Last updated: October 27, 2026

Jason Deveau Rosen, USPTO Patent Examiner

Listed by the USPTO as DEVEAU ROSEN, JASON

Tech Center 1600 • Art Units: 1638 1662

This examiner grants 80% of resolved cases

Analysis

DEVEAU ROSEN, JASON works in Tech Center 1600 and Art Unit 1638. The profile covers 842 resolved cases, with an 80.0% allowance rate and a median of 917 days to allowance. The 16.3% interview lift is positive, providing a potential benefit when interviews are used to clarify claim scope or address outstanding rejections.

The listed companies are Arista Cereal Technologies Pty Limited, Pioneer Hi-bred International Inc., and Bejo Zaden B V. The listed firms are MORRISON & FOERSTER LLP, MYERS BIGEL, P.A., and Berg Hill Greenleaf & Ruscitti LLP. The data supports a favorable overall prosecution outlook, with the median timeline remaining relevant to portfolio scheduling.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

80.0%
Allow Rate
+20.0% vs TC avg
876
Total Applications
+16.3%
Interview Lift
917
Avg Prosecution Days
Based on 842 resolved cases, 2023–2026

Rejection Statute Breakdown

3.0%
§101 Eligibility
13.8%
§102 Novelty
24.7%
§103 Obviousness
46.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19459391 SOYBEAN VARIETY 5PKTK47 Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
18556857 NEGATIVE-STRAND RNA VIRAL VECTOR AND PLANT GENOME EDITING METHOD WITHOUT TRANSFORMATION Non-Final OA ZHEJIANG UNIVERSITY
17432559 SUPPRESSION OF TARGET GENE EXPRESSION THROUGH GENOME EDITING OF NATIVE MIRNAS Final Rejection SYNGENTA CROP PROTECTION AG
19200689 Gene editing to provide insect resistance in crops Non-Final OA The Regents of the University of California
18874464 MIXED LINKAGE GLUCAN BIOSYNTHESIS BY CELLULOSE SYNTHASE-LIKE CSLF6 (1,3;1,4)-B-GLUCAN SYNTHASE Final Rejection University of Virginia Patent Foundation
19071964 TARGETED MUTAGENESIS OF TOBACCO BERBERINE BRIDGE ENZYME-LIKE NUCLEIC ACIDS Final Rejection North Carolina State University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jason Deveau Rosen's allowance rate?

80.0% of resolved applications examined by Jason Deveau Rosen were allowed (842 resolved cases), compared with 48.8% across Art Unit 1638 over the last five years.

Does an interview help with examiner Jason Deveau Rosen?

This examiner's interview lift is +16.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jason Deveau Rosen take to allow a patent?

Applications allowed by Jason Deveau Rosen took 917 days on average from filing to allowance.

Which art unit does examiner Jason Deveau Rosen work in?

Jason Deveau Rosen examines applications in Art Unit 1638 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month